OPKO Health to Participate in Jefferies Biotech Summit

Biopharmaceutical company to hold one-on-one investor meetings at annual Miami event

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

OPKO Health, Inc., a multinational biopharmaceutical and diagnostics company, announced that it will be participating in the Jefferies Biotech on the Beach Summit being held March 10-11, 2026 in Miami. The company's management team will be holding one-on-one meetings with investors registered for the event on March 11th.

Why it matters

OPKO is a major player in the rapidly growing biopharmaceutical and diagnostics industries, and its participation in high-profile industry events like the Jefferies Biotech Summit provides an opportunity to connect with investors and showcase its latest developments and growth strategies.

The details

The Jefferies Biotech on the Beach Summit is an annual event that brings together leading companies in the biotech and pharmaceutical sectors with institutional investors. OPKO's participation allows the company to highlight its discovery, development, and commercialization expertise, as well as its novel and proprietary technologies, to a targeted audience of potential investors.

  • The Jefferies Biotech on the Beach Summit will be held on March 10-11, 2026.
  • OPKO's management team will be holding one-on-one investor meetings on March 11, 2026.

The players

OPKO Health, Inc.

A multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets.

Jefferies Biotech on the Beach Summit

An annual event that brings together leading companies in the biotech and pharmaceutical sectors with institutional investors.

Got photos? Submit your photos here. ›

The takeaway

OPKO's participation in the Jefferies Biotech Summit demonstrates its commitment to engaging with the investment community and showcasing its capabilities in the rapidly evolving biopharmaceutical and diagnostics industries.